Measurement method for content of atropine sulfate in traditional Chinese medicine suppository containing belladonna liquid extract
A technology of atropine sulfate and belladonna liquid extract, which is applied in the field of determination of atropine sulfate content, can solve the problems that atropine sulfate detection can only identify the presence or absence of content, and can not detect the content, so as to achieve high purity, improve extraction purity, and avoid interference Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0028]Control chromatographic conditions: column: Agilent octadecylsilane bonded silica gel (Anglient Zorbax Eclipse XDB C-18, 3.5um) manufactured by Agilent Technologies, Inc., USA.
[0029] Mobile phase: A: phosphate buffer 0.05M KH2PO4, adjusted to pH = 3 with phosphoric acid solution; B: acetonitrile; same solvent elution (isocratic elution) A: B = 72%: 28%
[0030] The detection wavelength is 210nm.
[0031] Preparation of reference solution
[0032] Accurately weigh 106mg of atropine sulfate (Chinese institute for the control of pharmaceutical and biological products, for content determination, batch number: 100040-200510)) reference substance is dissolved in 10% sulfuric acid 50ml, the solution 0.5ml that will obtain is added mobile phase to atropine sulfate The solution concentration was 0.0424mg / ml. The final solution was used as the reference solution.
[0033] Preparation of the test solution
[0034] Test product: "Musk Hemorrhoid Suppository" (batch number: 09...
Embodiment 2
[0043] Control chromatographic conditions: column: with embodiment 1.
[0044] Mobile phase: A: phosphate buffer 0.03M KH2PO4 pH = 3; B: acetonitrile; same solvent elution (isocratic elution) A: B = 90%: 10%
[0045] Detection wavelength 400nm
[0046] Preparation of reference solution
[0047] Accurately weighed 106mg of atropine sulfate reference substance was dissolved in 5% sulfuric acid 40ml, 0.5ml of the resulting solution was added to the mobile phase until the solution concentration of atropine sulfate was 0.01mg / ml. The final solution was used as the reference solution.
[0048] Preparation of the test solution:
[0049] Test product: "Musk Hemorrhoid Suppository" manufactured by Mayinglong Pharmaceutical Group Co., Ltd. (Lot number: 091101)
[0050] Preparation method: 10% sulfuric acid 50ml is replaced with 5% sulfuric acid 70ml, control residue is 2500mg / ml in solution concentration, all the other are with embodiment 1, the solution that obtains uses as need t...
Embodiment 3
[0054] Control chromatographic conditions: column: with embodiment 1.
[0055] Mobile phase: A: phosphate buffer 0.07M KH2PO4 pH = 1, B: acetonitrile; same solvent elution (isocratic elution) A: B = 65%: 35%
[0056] Detection wavelength 210nm
[0057] Preparation of reference solution
[0058] Accurately weighed 106mg of atropine sulfate reference substance was dissolved in 5% sulfuric acid 80ml, 0.5ml of the solution obtained was added to the mobile phase until the solution concentration of atropine sulfate was 500mg / ml. The final solution was used as the reference solution.
[0059] Preparation of the test solution
[0060] Test product: "Musk Hemorrhoid Suppository" manufactured by Mayinglong Pharmaceutical Group Co., Ltd. (Lot number: 091101) preparation method: 10% sulfuric acid 50ml is replaced with 15% sulfuric acid 30ml, control residue is 0.01mg / ml in solution concentration, all the other are with embodiment 1, the solution that obtains uses as need testing solut...
PUM
Property | Measurement | Unit |
---|---|---|
separation | aaaaa | aaaaa |
separation | aaaaa | aaaaa |
separation | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com